Multi-spectroscopic methods investigation on the interaction of tenoxicam with DNA

Bing-Mi Liu1, Jun Zhang1, Yang Liu1

  • 1Department of Pharmacy, Liaoning University, Shenyang, People's Republic of China.

Insights

Tenoxicam (TXM), a non-steroidal anti-inflammatory drug, binds to calf thymus DNA (ct-DNA) via groove binding. This interaction, driven by hydrogen bonds or van der Waals forces, offers insights into TXM's anticancer pharmacological activity.

Area of Science:

  • Pharmacology
  • Molecular Biology
  • Biochemistry

Background:

  • Non-steroidal anti-inflammatory drugs (NSAIDs) exhibit chemopreventive and chemosuppressive properties against cancer cell lines.
  • NSAIDs exert anticancer effects by inhibiting biological processes at both protein and transcriptional levels.

Purpose of the Study:

  • To investigate the interaction mechanism between tenoxicam (TXM) and calf thymus DNA (ct-DNA).
  • To elucidate the binding mode and thermodynamic parameters governing the TXM-ct-DNA interaction.

Main Methods:

  • UV-visible spectrophotometry
  • Fluorescence spectroscopy
  • Viscosity measurements
  • DNA melting studies

Main Results:

  • Tenoxicam (TXM) binds to calf thymus DNA (ct-DNA) through groove binding.
  • Binding constants were determined as 7.67 × 10^3 M⁻¹ at 293 K and 5.48 × 10^3 M⁻¹ at 300 K.
  • Thermodynamic analysis indicated that hydrogen bonds and/or van der Waals forces are crucial for TXM-ct-DNA binding.

Conclusions:

  • The study reveals the specific binding mode of tenoxicam to DNA.
  • Findings provide a molecular basis for the pharmacological activity of TXM, particularly its potential anticancer effects.